Company News

中文

中文

Media Center

Medical Breakthrough: "Phage Commandos" Breach Barriers in 72 Hours! 5-Month-Old with Superbug Colonization Gains New Hope

2025-03-24

More
CreatiPhage Completes Pre-A Financing, Accelerating the Commercialization of Phage Therapy

Recently, CreatiPhage announced the completion of its Pre-A round of financing, exclusively invested by Xuhui STI. The funds raised will primarily be used to accelerate the market promotion of CreatiPhage's personalized phage therapy and phage-based products.

2025-04-22

More
CreatiPhage Great Achievement at the 2023 Maker in China Shanghai Competition

Recently, the 2023 Maker in China SME (Small Medium Enterprise) Innovation and Entrepreneurship Competition in Shanghai concluded. CreatiPhage participating for the first time, achieved remarkable results by winning the first place in the Life Health Track at the sub-competition level and eleventh place (Excellence Award) in the overall competition.

2024-03-25

More
CreatiPhage Recognized as Shanghai's Innovative SME

CreatiPhage was successfully selected as Shanghai's Innovative SMEs, known for their high level of specialization, strong innovation capabilities, and growth potential.

2024-03-25

More
Minhang biotech company leading the charge against antibiotic resistance

A biotech company in Minhang District's Xinzhuang Industrial Zone is trying to tackle antibiotic resistance by tapping the potential of bacteriophage (also known as phage, a group of viruses that infect bacteria).

2024-03-25

More
CreatiPhage's 2023 Highlights

Reflecting on 2023, CreatiPhage navigated through the seasons with significant moments worth remembering.

2024-03-25

More
New Phage Center Inaugurated: Jiahui Health Partners with CreatiPhage to Advance Clinical Translation of Phage Therapy

2023-02-15

More

　 1 　

Prev 1/1 Next

Add: 388 Fenglin Road, Shanghai

Tel: 0086-400-668-7738

About

Introduction

History

Specialist

Investors
Platforms

cPhageBank

Intelligent Phage Screening

Synthetic Phages
Pipelines

NatPhages

SynPhages

Personalized Therapy

Infection Contain
Research

Alliance Phage of China

Research progress
Media

Company News

Phage News
Contact

Careers

Contact

Patient Access

Official account

©Shanghai ICP reserve No. 2022031782-1 CreatiPhage Biotechnology Co., Ltd. All rights reserved. Designed by JCE

Links

                            
Home

Tel

Top